期刊文献+

姜黄素和安理申联合治疗老年性痴呆研究 被引量:3

Study on effect of combination of donepezil and curcumin in treating old patients with Alzheimer's disease
下载PDF
导出
摘要 目的探讨联合应用姜黄素和安理申对老年性痴呆患者认知功能和行为能力的改善作用。方法收集老年性痴呆患者90例,随机分为3个组,姜黄素和安理申联合治疗组30例,安理申治疗组30例,空白对照组30例。空白对照组不使用治疗痴呆药物。3组患者分别在治疗前和治疗3、6个月后进行MMSE评分、ADL评分的测评。结果姜黄素和安理申联合治疗组患者治疗后认知、行为能力较安理申治疗组改善明显(P<0.01)。结论姜黄素和安理申联合治疗对老年性痴呆患者认知、行为能力有显著改善作用。 Objective To investigate the effect of combination of donepezil and curcumin on cognitive function and behav- ioral abilities in treating old patients with Alzheimer's disease. Methods Totally 90 patients with Alzheimer^s disease were randomly divided into 3 groups: the group treated with donepezil, group treated with donepezil and curcumin, and control group without any medicine or herb to prevent Alzheimer's disease. MMSE scale and ADL scale of the three groups were assessed and compared before treatment and 3 months, 6 months after treatment. Results The cognitive function and behavioral abilities were improved markedly in the group treated with donepezil and curcumin (P〈0.01). Conclusion Combination of donepezil and curcumin can markedly ameliorate the cognitive function and behavioral abilities in patients with Alzheimer's disease.
出处 《中国实用神经疾病杂志》 2012年第17期13-15,共3页 Chinese Journal of Practical Nervous Diseases
关键词 姜黄素 安理申 老年性痴呆 认知功能 行为能力 Curcumin Donepezil Alzheimer's disease Cognitive function Behavioral ability
  • 相关文献

参考文献8

  • 1Mischoulon D. Raab MF. The role of folate in depression and Dementia[J]. J Clin Psychiatry, 2007,68(11) :28-33.
  • 2Howard RJ. J uszczak E, Ballard CG, et al. Donepezil for the treatment of agitation in Alzheimer’s disease [J]. N Engl J Med,2007,357(14) :1 382.
  • 3Gomez G, Mansouraty G. Gardea J.et al. Acceleration of oxidative protein folding by curcumin through novel non-redox chemistry [J]. Biochem Biophys Res Commun,2007,364(3) :561-566.
  • 4Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as “Curecumin”; from kitchen to clinic[J]. Biochem Pharmacol, 2008,75:787-809.
  • 5Jorm AF, Jolley D, The incidence of dementia: A meta analysis [J]. Neurology, 1998,51 :728-733.
  • 6David SG. Clinical experience with donepezil hydrochloride: a case study perspective[J].Adv Therapy,1997,14 (2) :305-311.
  • 7Vitali M, Venturelli E. Galimberti D,et al. Analysis of the genes coding for subunit 10 and 15 of cytochrome C oxidase in Alzh[J].s disease[J]. J Neural Transm ,2009,116(12) tl 635-1 641.^.
  • 8Yang F,Lim GP,Begum AN,et al. Curcumin inhibits formation of amyloid beta oligomers and fibrils,binds plaques,and reduces amyloid in vivo[J]. J Biol Chem.2005,280:5 892-5 901.

同被引文献48

  • 1唐农,黄立武.对血管性痴呆从肺论治的思考[J].广西中医学院学报,2004,7(4):1-3. 被引量:50
  • 2王永炎.关于提高脑血管疾病疗效难点的思考[J].中国中西医结合杂志,1997,17(4):195-196. 被引量:619
  • 3Tam JH, Pasternak SH. Amyloid and Alzheimer's disease: inside and out[J]. Can J Neurol Sci,2012, 39(3) :286 -298.
  • 4Lozano R, Naghavi M, Foreman K, et al. Global and regional mortal- ity from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 [ J ]. Lancet, 2013, 380(9859) :2095 -2128.
  • 5Wang Q, Xu Y, Chen JC, et al. Stromal cell - derived factor 1 c- de- creases 13 - amyloid deposition in Alzheimer's disease mouse model [J]. Brain Res, 2012, 1459(1) :15 -26.
  • 6杜俊蓉,旷喜,陈娅姝,等.13K/AKT信号通路在藁本内酯治疗老年性痴呆有效性中的作用[J].中国药理学与毒理学杂志,2012,26(3):421-422.
  • 7Borgegard T, Gustavsson S, Nilsson C, et al. Alzheimer's disease: presenilin 2 - sparing 5' - secretase inhibition is a tolerable Aβ peptide - lowering strategy [ .l ]..1 Neurosci, 2012, 32 ( 48 ) : 17297 - 17305.
  • 8Hamilton A, Holscher C. The effect of ageing on neurogenesis and ox- idative stress in the APP(swe)/PSI (deltaE9) mouse model of Alzhe- imer's disease[ Jl. Brain Res, 2012, 1449 ( 1 ) :83 - 93.
  • 9Chow VW, Mattson MP, Wong PC, et al. An overview of APP pro- cessing enzymes and products [ J]. Neuromolecular Med, 2010, 12 (1):1 -12.
  • 10Nemirovsky A, Shapiro J, Baron R, et al. Active A13 vaccination fails to enhance amyloid clearance in a mouse model of Alzheimer's disease with AI342 - driven pathology [ J ]. J Neuroimmunol, 2012, 247 ( 1 -2) :95 -99.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部